The University of Southampton
University of Southampton Institutional Repository

Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma

Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma
Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma
Rationale: Serum periostin has been proposed as a biomarker of Th2 airway inflammation in asthma. We thus measured serum periostin in a large cohort of patients with severe asthma as well as in those with milder asthma and healthy controls, to gain insight into the value of this biomarker in asthma stratification. Methods: Serum samples from 126 healthy controls (HC), 93 non-steroid treated mild asthmatics (MA), 35 asthmatics on low dose corticosteroids +/- LABA (ModA) and 276 severe treatment-resistant asthmatics (SA) were assayed for serum periostin by ELISA (Shino-Test Corporation, Kanagawa, Japan) and the results related to clinical and inflammatory markers. Results: Group median serum periostin levels were significantly (p<0.0001) lower in both the steroid treated asthma groups (ModA and SA) than the HC or MA groups, although there was greater spread in SA with 21% of values ± the normal range. Tertile analysis of the SA serum periostin identified that those in the upper tertile (≥79 ng/ml) had significantly higher sputum eosinophils (p=0.001), peripheral blood eosinophilia (p=0.002), FeNO (p=0,001) and total IgE (p=0.01) as well as lower FEV1 % predicted (p=0.02) than those in the lowest tertile (≤58ng/ml). Serum periostin measures did not appear related to age, BMI or atopic status. Conclusion: Steroid treatment in asthma is associated with significantly lower serum periostin measures than in non-steroid treated asthma, although a sub-population of severe asthmatics have levels that associate with eosinophilic inflammation. Funding: WSAC was funded by the Medical Research Council UK.
0903-1936
Rupani, Hitasha
cbc7068a-4279-4c8e-b83f-353210711062
Lau, Laurie
2af8045d-6162-4939-aba7-28dd2f60f6a8
Ono, Junya
ca04523f-02e6-4274-aefe-3c4bac46a8e6
Ohta, Shoichiro
042f953e-8480-476a-b122-78f01390b80a
Barber, Clair
ff31b460-34c3-466c-90e4-f70b3e954c82
Elliott, Scott P
f3234b8e-63df-45b3-a832-26b9a1acaf7f
Brown, Tom
fdd42359-a39d-4f22-b48d-015d9b94ec76
Kurukulaaratchy, Ramesh
9c7b8105-2892-49f2-8775-54d4961e3e74
Chauhan, Anoop
4f606144-8948-4f82-8cb1-e57e7a05a8ed
Izuhara, Kenji
cf69a8d3-6644-4bad-b27f-7d0abae2b0af
Howarth, Peter
ff19c8c4-86b0-4a88-8f76-b3d87f142a21
Rupani, Hitasha
cbc7068a-4279-4c8e-b83f-353210711062
Lau, Laurie
2af8045d-6162-4939-aba7-28dd2f60f6a8
Ono, Junya
ca04523f-02e6-4274-aefe-3c4bac46a8e6
Ohta, Shoichiro
042f953e-8480-476a-b122-78f01390b80a
Barber, Clair
ff31b460-34c3-466c-90e4-f70b3e954c82
Elliott, Scott P
f3234b8e-63df-45b3-a832-26b9a1acaf7f
Brown, Tom
fdd42359-a39d-4f22-b48d-015d9b94ec76
Kurukulaaratchy, Ramesh
9c7b8105-2892-49f2-8775-54d4961e3e74
Chauhan, Anoop
4f606144-8948-4f82-8cb1-e57e7a05a8ed
Izuhara, Kenji
cf69a8d3-6644-4bad-b27f-7d0abae2b0af
Howarth, Peter
ff19c8c4-86b0-4a88-8f76-b3d87f142a21

Rupani, Hitasha, Lau, Laurie, Ono, Junya, Ohta, Shoichiro, Barber, Clair, Elliott, Scott P, Brown, Tom, Kurukulaaratchy, Ramesh, Chauhan, Anoop, Izuhara, Kenji and Howarth, Peter (2014) Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma. European Respiratory Journal, 44 (Suppl 58), [P3986].

Record type: Meeting abstract

Abstract

Rationale: Serum periostin has been proposed as a biomarker of Th2 airway inflammation in asthma. We thus measured serum periostin in a large cohort of patients with severe asthma as well as in those with milder asthma and healthy controls, to gain insight into the value of this biomarker in asthma stratification. Methods: Serum samples from 126 healthy controls (HC), 93 non-steroid treated mild asthmatics (MA), 35 asthmatics on low dose corticosteroids +/- LABA (ModA) and 276 severe treatment-resistant asthmatics (SA) were assayed for serum periostin by ELISA (Shino-Test Corporation, Kanagawa, Japan) and the results related to clinical and inflammatory markers. Results: Group median serum periostin levels were significantly (p<0.0001) lower in both the steroid treated asthma groups (ModA and SA) than the HC or MA groups, although there was greater spread in SA with 21% of values ± the normal range. Tertile analysis of the SA serum periostin identified that those in the upper tertile (≥79 ng/ml) had significantly higher sputum eosinophils (p=0.001), peripheral blood eosinophilia (p=0.002), FeNO (p=0,001) and total IgE (p=0.01) as well as lower FEV1 % predicted (p=0.02) than those in the lowest tertile (≤58ng/ml). Serum periostin measures did not appear related to age, BMI or atopic status. Conclusion: Steroid treatment in asthma is associated with significantly lower serum periostin measures than in non-steroid treated asthma, although a sub-population of severe asthmatics have levels that associate with eosinophilic inflammation. Funding: WSAC was funded by the Medical Research Council UK.

This record has no associated files available for download.

More information

Published date: September 2014
Venue - Dates: Munich European Respiratory Society Congress, Munich, Germany, 2014-09-06 - 2014-09-10

Identifiers

Local EPrints ID: 422524
URI: http://eprints.soton.ac.uk/id/eprint/422524
ISSN: 0903-1936
PURE UUID: 6283d505-ae7b-4a9c-8fc6-a201a74b9a6d
ORCID for Clair Barber: ORCID iD orcid.org/0000-0001-5335-5129
ORCID for Ramesh Kurukulaaratchy: ORCID iD orcid.org/0000-0002-1588-2400

Catalogue record

Date deposited: 25 Jul 2018 16:30
Last modified: 16 Mar 2024 03:09

Export record

Contributors

Author: Hitasha Rupani
Author: Laurie Lau
Author: Junya Ono
Author: Shoichiro Ohta
Author: Clair Barber ORCID iD
Author: Scott P Elliott
Author: Tom Brown
Author: Anoop Chauhan
Author: Kenji Izuhara
Author: Peter Howarth

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×